Halliburton Company Form 4 Filings

HALLIBURTON CO (HAL) director and executive officer Jeffrey Shannon Slocum reported selling 52,572 shares of Halliburton common stock on August 19, 2026 in an open-market transaction under a Rule 10b5-1 trading plan adopted on May 8, 2026. The weighted average sale price was $35.09 per share, with individual sale prices ranging from $35.00 to $35.43. Following this sale, Slocum directly held 118,729.952 shares of Halliburton common stock. He also reported outstanding stock options to buy Halliburton common stock, including options with exercise prices of $49.61 for 12,090 underlying shares expiring January 2, 2028, and $55.68 for 3,722 underlying shares expiring January 3, 2027.

HALLIBURTON CO (HAL) director and executive officer Jeffrey Shannon Slocum reported a sale of 16,121 shares of Common Stock on August 18, 2026 at a weighted average price of $35.083 per share, under a Rule 10b5-1 trading plan adopted on May 8, 2026. After this transaction, he directly holds 171,301.952 shares of Halliburton common stock and retains employee stock options over additional shares.

Halliburton Co (HAL) insider Jeffrey Allen Miller, Director, President & CEO, reported selling 124,483 shares of common stock on August 18, 2026 at $35.00 per share. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on May 13, 2026. Following this transaction, Miller directly holds 889,388.615 shares of Halliburton common stock, including 844.595 shares acquired through the Halliburton Employee Stock Purchase Plan for the period ending March 31, 2026. He also continues to hold stock options covering 128,500 shares at an exercise price of $43.38 expiring December 6, 2027, and options covering 69,500 shares at an exercise price of $53.54 expiring December 7, 2026.

Halliburton director Maurice S. Smith reported a new compensation award of 1,079.638 stock equivalent units linked to Halliburton common stock. These units were acquired at a stated price of $0.00 under the company’s Directors' Deferred Compensation Plan and convert to common shares on a one-for-one basis following cessation as a director.

The filing also lists existing awards of restricted stock units from 2023, 2024, and 2025, each representing the right to receive Halliburton common shares. Footnotes explain that stock equivalent units accrue from director fees and dividends, using closing prices of $38.63, $33.90, and $34.09 on specified dates.

HALLIBURTON CO Executive Vice President and Chief Financial Officer Eric Carre reported an open-market sale of 24,778 shares of common stock at $35.89 per share on June 18, 2026. The sale was effected under a Rule 10b5-1 trading plan adopted on March 18, 2026.

Following this transaction, Carre directly holds 148,520.478 shares of Halliburton common stock, including 243.855 shares accumulated through dividend reinvestment as of June 22, 2026. He also holds stock options to buy 30,100 shares at $53.54 expiring December 7, 2026, 34,425 shares at $43.38 expiring December 6, 2027, and 50,100 shares at $31.44 expiring December 5, 2028.

Halliburton Company executive Van H. Beckwith reported an open-market sale of 198,349 shares of Common Stock. The shares were sold on May 15, 2026 at a weighted average price of $41.29 per share, across multiple trades between $41.15 and $41.38.

After this transaction, Beckwith directly holds 146,186.49 Halliburton shares. The sale was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on August 13, 2025, indicating the sales were scheduled in advance rather than timed discretionarily.

Halliburton Company executive Michael Casey, President – Western Hemisphere, sold 20,348 shares of common stock in open-market transactions. The sales occurred on May 5, 2026 at prices of $42.00 and $41.84 per share and were effected under a Rule 10b5-1 trading plan adopted on February 3, 2026. A footnote also notes 656.906 shares previously purchased through the Halliburton Employee Stock Purchase Plan for the period ending March 31, 2026.

Halliburton director Tobi M. Young reported selling common stock and holding restricted stock units. On April 30, 2026, Young sold a total of 6,125 shares of Halliburton common stock in open‑market transactions at prices of $41.72 and $41.725 per share.

Young also holds 12/2025 Restricted Stock Units tied to 7,485 underlying shares of common stock. Each restricted stock unit represents the right to receive one share, vesting in one year on the first anniversary of the award, with delivery at vesting or after cessation as a director if deferred.

Halliburton Company senior vice president and treasurer Timothy McKeon sold 8,655 shares of common stock at $42.00 per share in an open-market transaction. The sale was carried out on April 30, 2026 under a pre-arranged Rule 10b5-1 trading plan adopted on August 12, 2025.

Following this sale, McKeon directly owned 72,976 shares of Halliburton common stock. He also held several outstanding stock option awards to buy Halliburton common stock at exercise prices between $31.44 and $53.54 per share, with expiration dates from late 2026 through late 2028.

Halliburton director Maurice S. Smith reported a compensation-related equity grant and updated his deferred and restricted stock holdings. On March 30, 2026, he received 827.815 stock equivalent units at a stated price of $0.00 under Halliburton’s Directors' Deferred Compensation Plan. These stock equivalent units convert into common stock on a one-for-one basis and are settled in company shares after his service as a director ends. A portion of the units reflects quarterly dividends and fees, based on closing prices of $38.63 and $39.26 in March 2026, and the plan is described as an ongoing securities acquisition program. Following this grant, Smith directly holds 13,768.454 stock equivalent units, in addition to several series of restricted stock units tied one-for-one to common shares, including 12/2025, 12/2024, 12/2023, and 03/2023 awards with underlying share amounts of 7,517.9400, 6,292.1000, 5,093.0800, and 4,070.4900, respectively. The restricted stock units vest over time, with the referenced award terms stating vesting after one year, and shares are delivered either upon vesting or, if he elected deferral, after his board service concludes.

Halliburton Director, President & CEO Jeffrey Allen Miller sold 158,455 shares of common stock in an open-market sale at $40.0000 per share. The transaction was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on February 13, 2025.

Following the sale, Miller directly owns 1,013,027.0200 shares of Halliburton common stock. He also holds vested options to buy 128,500 shares at an exercise price of $43.3800 expiring on December 6, 2027, and 69,500 shares at $53.5400 expiring on December 7, 2026.

Halliburton Company executive Van H. Beckwith, EVP, Secretary and Chief Legal Officer, reported an open-market sale of 19,618 shares of common stock at $33.82 per share. After this transaction, he directly holds 344,535.49 shares. The sale was made under a pre-arranged Rule 10b5-1 trading plan adopted on August 13, 2025, indicating it was scheduled in advance rather than timed discretionarily.

Halliburton Company director and executive Jeffrey Shannon Slocum reported an open-market sale of 5,441 shares of Common Stock at a price of $33.82 per share. After this transaction, he directly holds 187,422.952 shares of Halliburton common stock.

The sale was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on August 7, 2025. Slocum also continues to hold options to buy Halliburton common stock, including options with exercise prices of $49.61 and $55.68 per share that are exercisable for 12,090 and 3,722 underlying shares, respectively, with expiration dates in early 2028 and early 2027.

Halliburton Company senior vice president and treasurer Timothy McKeon reported an open-market sale of common stock. On March 6, 2026, he sold 3,846 shares of Halliburton common stock at a price of $34.37 per share. After this transaction, he continued to hold 81,631 shares of common stock directly.

The filing notes that this sale was carried out under a pre-established Rule 10b5-1 trading plan adopted by McKeon on August 12, 2025, which allows insiders to schedule trades in advance. The form also lists his outstanding options to buy common stock as ongoing holdings.

Halliburton Company Senior VP and Treasurer Timothy McKeon reported a tax-related share transfer, not an open-market trade. On March 5, 2026, he transferred 1,239 shares of common stock at $36.00 per share to Halliburton to cover federal tax withholding when performance-based restricted shares vested.

After this tax-withholding disposition, McKeon directly owned 85,477 Halliburton common shares. He also continued to hold stock options, with 8,700, 5,800, and 5,100 options to buy common stock outstanding under the company’s Stock and Incentive Plan.

Halliburton Company senior vice president Jill D. Sharp reported a tax-related share transfer, not an open-market sale. On March 5, 2026, she transferred 1,239 shares of Halliburton common stock at $36.00 per share to Halliburton to satisfy federal tax withholding obligations tied to restricted shares.

The footnotes state these Performance Unit shares were issued on February 27, 2026, when Halliburton’s stock closed at $36.00 on the New York Stock Exchange, and shares were then withheld for tax reporting on March 5, 2026. After this transaction, she directly owned 52,795.081 common shares, plus vested option holdings shown as 16,733 and 14,197 options to buy common stock.

Halliburton Company executive Rami Yassine reported a tax-related share transfer, not an open-market sale. On the lapse of restrictions for shares issued under the Stock and Incentive Plan, he transferred 1,407 shares of common stock to Halliburton at $36.00 per share to cover federal tax withholding obligations.

After this tax-withholding disposition, he directly held 162,061.84 Halliburton common shares. Footnotes state the Performance Unit shares were issued on February 27, 2026 at a closing price of $36.00, with shares withheld for tax reporting on March 5, 2026.

Halliburton Company director, EVP and COO Jeffrey Shannon Slocum transferred 3,404 shares of common stock at $36.00 per share to Halliburton to cover federal tax withholding obligations. This tax-withholding disposition occurred when restrictions lapsed on shares issued under the company’s Stock and Incentive Plan.

The footnotes state that the performance unit shares were issued on February 27, 2026, when Halliburton’s common stock closed at $36.00, and shares were withheld for tax reporting on March 5, 2026. After this transaction, Slocum directly held 192,863.952 shares of common stock, along with outstanding options to buy additional shares.

Halliburton Company executive Lawrence J. Pope reported a tax-related share transfer rather than an open-market trade. On March 5, 2026, he transferred 12,729 shares of common stock at $36.00 per share back to Halliburton to satisfy federal tax withholding obligations tied to restricted shares under the Stock and Incentive Plan.

The footnotes state that the performance unit shares were issued on February 27, 2026 at a New York Stock Exchange closing price of $36.00, and shares were withheld for tax reporting on March 5, 2026. After this transaction, Pope directly owned 433,254.685 shares of common stock, and continued to hold several option grants to buy common stock, including positions with 51,100, 34,300, and 30,500 options outstanding.

Halliburton Company executive Van H. Beckwith reported a tax-related share transfer rather than an open-market trade. On March 5, 2026, 12,729 shares of Halliburton common stock at $36.00 per share were transferred to Halliburton to satisfy federal tax withholding tied to restricted stock vesting and performance unit shares. Following this tax-withholding disposition, Beckwith directly holds 364,153.49 Halliburton shares.

Halliburton Company’s EVP & Chief Financial Officer Eric Carre transferred shares to the company to cover taxes tied to a stock award. On a tax-withholding disposition dated March 5, he delivered 12,729 shares of common stock at $36.00 per share to Halliburton to satisfy federal tax obligations upon the lapse of restrictions on performance-based stock issued under the Stock and Incentive Plan. After this transaction, he directly held 173,054.623 shares of Halliburton common stock, and the filing also lists several vested options to buy common stock that remain outstanding.

Halliburton Company Director, President & CEO Jeffrey Allen Miller reported a tax-related share transfer. On March 5, 2026, he disposed of 45,572 shares of Halliburton common stock at $36.00 per share to Halliburton to satisfy federal tax withholding tied to vesting of performance-based shares.

After this transaction, he directly held 1,171,482.02 Halliburton common shares. The filing also reports direct holdings of options to buy Halliburton common stock covering 128,500 shares and 69,500 shares, with these option positions reported as holdings rather than new option transactions.

Yassine Rami reported acquisition or exercise transactions in this Form 4 filing.

Halliburton President – Eastern Hemisphere Rami Yassine received a stock award of 5,897 common shares on February 27, 2026, valued at $36 per share. The award reflects the achievement of performance criteria tied to performance share units granted on January 3, 2023, under Halliburton's Performance Unit Program. Following this grant, his direct common stock holdings increased to 163,468.84 shares, alongside several option awards to buy common stock reported as ongoing holdings.

Halliburton Company director and EVP/COO Jeffrey Shannon Slocum acquired 8,845 shares of common stock on a performance-based award. The shares were issued on February 27, 2026, after achievement of performance criteria tied to performance share units granted on January 3, 2023, increasing his direct holdings to 196,267.952 shares.

Halliburton senior vice president Jill D. Sharp acquired 5,085 shares of common stock on February 27, 2026 at $36.00 per share. The shares were issued upon achievement of performance criteria and vesting of performance share units granted on January 3, 2023. Following this award, she directly holds 54,034.081 common shares and has option positions covering 16,733 and 14,197 shares of common stock.

Halliburton Company executive Lawrence J. Pope received 32,347 shares of common stock as an equity award. The Form 4 shows these shares were issued on February 27, 2026 upon achievement of performance criteria and vesting of performance share units originally granted on January 3, 2023 under the Halliburton Company Performance Unit Program.

Following this grant, Pope directly holds 445,983.685 shares of Halliburton common stock. The filing also reports updated direct holdings of options to buy Halliburton common stock in separate option awards, without listing new option exercises or sales.

Beckwith Van H. reported acquisition or exercise transactions in this Form 4 filing.

Halliburton Company executive Van H. Beckwith received 32,347 shares of common stock on February 27, 2026, at a reported price of $36.00 per share. These shares were issued upon achievement of performance criteria and vesting of performance share units granted on January 3, 2023, under Halliburton's Performance Unit Program. Following this award, Beckwith directly holds a total of 376,882.49 Halliburton common shares.

Halliburton Company Senior VP and Treasurer Timothy McKeon acquired 5,085 shares of common stock on February 27, 2026 through the vesting of performance share units at a stated value of $36.00 per share. Following this award, he directly holds 86,716 common shares. The filing also lists updated direct holdings of several option awards to buy common stock, with post-transaction balances of 8,700, 5,100, and 5,800 options, reflecting outstanding equity incentives rather than open-market trades.

Halliburton Company Executive Vice President and Chief Financial Officer Eric Carre acquired 32,347 shares of common stock on February 27, 2026 at $36.00 per share. These shares were issued upon achievement of performance criteria and vesting of performance share units granted on January 3, 2023.

Following this award, Carre directly owns 185,783.623 shares of Halliburton common stock. He also holds options to buy common stock covering 50,100 shares, 34,425 shares, and 30,100 shares in separate option awards.

Halliburton Company Director, President & CEO Jeffrey Allen Miller reported an equity award rather than an open-market trade. On February 27, 2026, he acquired 115,811 shares of common stock at $36.00 per share, issued upon achievement of performance criteria and vesting of performance share units granted on January 3, 2023 under the Halliburton Company Performance Unit Program. Following this grant, his directly held common stock increased to 1,217,054.02 shares, and his directly held options to buy common stock totaled 128,500 and 69,500 shares in two separate option positions.

Halliburton director Margaret Katherine Banks reported selling 2,600 shares of Halliburton common stock on 01/26/2026 at a price of $34.175 per share. After this sale, she directly holds 14,043 shares of Halliburton common stock. In addition, she holds restricted stock units from awards made in 12/2025, 12/2022, and 12/2021, covering 7,485, 5,286.68, and 8,523.5 underlying shares of common stock, respectively. Each restricted stock unit represents the right to receive one share of common stock, generally vesting one year after the award date, with shares delivered upon vesting or, if elected, after she ceases to serve as a director.

Halliburton director, president and CEO Jeffrey Allen Miller reported an option exercise and share sale. On January 23, 2026, he exercised an option to buy 171,200 shares of common stock at $31.44 per share, increasing his direct holdings to 1,272,443.02 shares. The same day, he sold 171,200 shares of common stock at $34.96 per share under a Rule 10b5-1 trading plan adopted on February 13, 2025, leaving him with 1,101,243.02 shares directly owned.

Following the transactions, he no longer holds the exercised option for 171,200 shares, but continues to hold options to buy 128,500 shares at $43.38 per share expiring on December 6, 2027, and options to buy 69,500 shares at $53.54 per share expiring on December 7, 2026, all reported as directly owned.

Halliburton executive Van H. Beckwith, EVP, Secretary and CLO, reported an option exercise and share sale. On January 23, 2026, he exercised options to buy 54,348 shares of common stock at $23.57 per share, increasing his direct holdings to 398,883.49 shares. That same day, he sold 54,348 common shares at $34.96 per share under a Rule 10b5-1 trading plan adopted on August 13, 2025, leaving him with 344,535.49 directly owned shares. The options exercised were fully disposed of in this transaction.

Halliburton Company executive Jeffrey Shannon Slocum, a director and EVP/COO, reported two transactions in Halliburton common stock. On January 8, 2026, 7,912 shares were transferred to Halliburton to cover federal tax withholding when previously granted restricted stock vested, at a reference price of $29.60 per share under the company’s Stock and Incentive Plan. On January 9, 2026, he sold 23,895 shares of common stock at an average price of $32.30 per share under a pre‑arranged Rule 10b5‑1 trading plan adopted on August 7, 2025. After these transactions, he directly holds 187,422.952 shares of Halliburton common stock and stock options covering 12,090 and 3,722 shares with exercise prices of $49.61 and $55.68, respectively.

Halliburton Company executive Van H. Beckwith, EVP, Secretary and CLO, reported two stock transactions in Halliburton common shares. On January 8, 2026, he transferred 6,163 shares to Halliburton at $29.60 per share to cover federal tax withholding tied to vested stock granted under the company’s Stock and Incentive Plan. The vested stock relates to awards granted between 2022 and 2025.

On January 9, 2026, he sold 17,798 shares at $32.30 per share in an open-market transaction carried out under a Rule 10b5-1 trading plan adopted on August 13, 2025. After these transactions, he beneficially owns 344,535.49 shares of Halliburton common stock directly and holds an option to buy 54,348 shares at an exercise price of $23.57 expiring on January 15, 2030.

Halliburton Company executive Rami Yassine, President - Eastern Hemisphere, reported an automatic share transfer to cover taxes tied to vested stock awards. On January 8, 2026, 3,687 shares of Halliburton common stock were transferred to the company to satisfy federal tax withholding obligations under its Stock and Incentive Plan at a reference price of $29.60 per share. After this withholding transaction, Yassine directly beneficially owned 157,571.84 shares of Halliburton common stock. The footnotes explain that the withheld shares relate to stock that vested in early January 2026 from grants made between 2021 and 2025, and that the reported total reflects his corrected direct beneficial ownership from a recently amended Form 3/A.

Halliburton (HAL) senior vice president Jill D. Sharp reported an automatic share withholding to cover taxes on recently vested stock awards. On January 8, 2026, 2,789 shares of common stock were transferred to Halliburton Company to satisfy federal tax withholding obligations related to restricted stock that vested on January 2, 3, and 4, 2026 at a reference price of $29.60 per share.

After this tax-related transfer, Sharp beneficially owned 48,949.081 shares of Halliburton common stock directly. She also held employee stock options directly to buy 14,197 shares at an exercise price of $55.68, expiring January 3, 2027, and 16,733 shares at an exercise price of $49.61, expiring January 2, 2028.

Halliburton Company executive Richard Mark, President - Western Hemisphere, reported a routine tax-related share withholding. On January 8, 2026, 7,469 shares of Halliburton common stock were transferred to the company at a price of $29.60 per share to cover federal tax withholding when previously granted restricted stock vested. After this transaction, Mark beneficially owned 480,691.517 shares of common stock.

The filing also lists existing stock options held directly by Mark, including options to buy 43,924 shares at $27.14 expiring December 20, 2028, 24,019 shares at $49.61 expiring January 2, 2028, and 17,119 shares at $55.68 expiring January 3, 2027. These options are holdings and not new option grants.

Halliburton Company executive Lawrence J. Pope, EVP and Chief Administrative Officer, reported a tax-related share transfer. On January 8, 2026, he transferred 6,163 shares of Halliburton common stock to the company at a reference price of $29.60 per share to cover federal tax withholding tied to the vesting of previously granted restricted stock under the Stock and Incentive Plan. After this transaction, he beneficially owned 413,636.685 shares of common stock directly.

The filing also lists outstanding stock options held directly by Pope, covering 51,100 shares at $31.44 expiring in 2028, 34,300 shares at $43.38 expiring in 2027, and 30,500 shares at $53.54 expiring in 2026. The footnotes clarify that the withheld shares relate to awards granted between 2022 and 2025 that vested in early January 2026.

Halliburton Company Director, President & CEO Jeffrey Allen Miller reported a routine share transfer related to tax withholding. On January 8, 2026, he transferred 29,847 shares of Halliburton common stock at $29.60 per share to Halliburton to cover federal tax obligations tied to the vesting of restricted stock granted between 2022 and 2025 under the company’s Stock and Incentive Plan. After this transaction, he directly beneficially owned 1,101,243.02 shares of common stock. He also held stock options directly, including 171,200, 128,500, and 69,500 options to buy common stock with exercise prices of $31.44, $43.38, and $53.54, respectively, and expiration dates from 2026 to 2028.

Halliburton senior vice president and treasurer Timothy McKeon reported a tax-related share transfer to the company. On January 8, 2026, 1,105 shares of Halliburton common stock were transferred to Halliburton Company to cover federal tax withholding obligations that arose when restricted stock vested under the company’s Stock and Incentive Plan. The plan allows the executive to satisfy withholding taxes by delivering unrestricted shares back to the issuer instead of paying cash.

After this withholding transaction, McKeon beneficially owned 81,631 shares of Halliburton common stock directly. He also held stock options giving the right to buy additional Halliburton shares, including options for 8,700 shares at an exercise price of $31.44, 5,800 shares at $43.38, and 5,100 shares at $53.54, each with stated expiration dates between December 2026 and December 2028. The vesting that triggered the tax withholding related to stock granted between January 2022 and January 2025, based on a closing market price of $29.60 on January 2, 2026.

Halliburton Company executive Stephanie Spoelker Holzhauser, SVP & Chief Accounting Officer, transferred 4,336 shares of common stock to Halliburton on January 8, 2026 to cover federal tax withholding on vested stock awards. The shares were valued at $29.60 per share, based on the January 2, 2026 New York Stock Exchange closing price, as allowed under the company’s Stock and Incentive Plan. After this withholding-related transfer, she beneficially owned 68,974.422 shares of Halliburton common stock directly.

She also continued to hold stock options directly, including options exercisable for 9,688 shares of common stock at an exercise price of $49.61 per share expiring January 2, 2028, and options for 7,994 shares at $55.68 per share expiring January 3, 2027. The filing characterizes the reported share movement as satisfying tax obligations tied to previously granted restricted stock that vested in early January 2026.

Halliburton Company’s EVP & Chief Financial Officer Eric Carre reported a routine share withholding related to equity compensation. On January 8, 2026, 6,283 shares of common stock were transferred to Halliburton to cover federal tax withholding triggered by the lapse of restrictions on previously granted stock under the company’s Stock and Incentive Plan, at a reference price of $29.60 per share.

After this tax-related transaction, Carre beneficially owned 153,436.623 shares of Halliburton common stock directly. He also held vested stock options directly, including 50,100 options with a $31.44 exercise price expiring December 5, 2028, 34,425 options at $43.38 expiring December 6, 2027, and 30,100 options at $53.54 expiring December 7, 2026.

Halliburton Company officer updates insider holdings in amended report. The President - Eastern Hemisphere of Halliburton, filing individually, corrected his direct beneficial ownership after an administrative error was identified.

Following the correction, he directly holds 147,163.837 shares of Halliburton common stock. He also holds several stock options: an option to buy 11,775 shares at $24.68 per share exercisable until 01/02/2030, an option to buy 9,517 shares at $27.30 per share until 01/02/2029, an option to buy 4,323 shares at $49.61 per share until 01/02/2028, and an option to buy 7,829 shares at $43.84 per share until 08/14/2026. The issuer is Halliburton Co (HAL), and the earliest transaction date reported is 01/02/2026.

Halliburton Company executive reports stock award and planned share sale

A Halliburton Company executive serving as EVP and Chief Administrative Officer reported equity transactions in Halliburton common stock. On January 2, 2026, the reporting person acquired 34,968 shares of common stock pursuant to the Halliburton Company Stock and Incentive Plan, which allows surrender of shares to satisfy tax withholding. The closing price of Halliburton common stock on the New York Stock Exchange on that grant date was $29.60 per share.

On January 5, 2026, the executive sold 100,000 shares of common stock at a price of $32.25 per share pursuant to a Rule 10b5-1 trading plan adopted on August 8, 2025. Following these transactions, the executive directly beneficially owned 419,799.685 shares of Halliburton common stock and held vested stock options covering additional shares with exercise prices between $31.44 and $53.54.

Halliburton Company reported an insider equity award for a senior executive. On January 2, 2026, a director and Executive Vice President & Chief Operating Officer received 56,178 shares of common stock under the Halliburton Company Stock and Incentive Plan. The plan allows shares to be surrendered to Halliburton to cover tax withholding obligations. The closing price of Halliburton common stock on the New York Stock Exchange on the grant date was $29.60 per share. After this grant, the insider directly beneficially owned 219,229.952 shares of common stock. The filing also shows stock options with exercise prices of $55.68 (3,722 shares, expiring January 3, 2027) and $49.61 (12,090 shares, expiring January 2, 2028), while an older option expiring January 4, 2026 is now at zero.

Halliburton Company executive equity update: A Halliburton Co (HAL) officer, listed as President - Western Hemisphere, reported receiving 41,156 shares of common stock on 01/02/2026 under the Halliburton Company Stock and Incentive Plan. The grant is valued using the New York Stock Exchange closing price of $29.60 on the grant date. After this award, the reporting person beneficially owns 488,160.517 Halliburton shares, which includes 2,013.910 shares accumulated through dividend reinvestment as of December 31, 2025. The filing also notes a stock option for 28,604 shares at an exercise price of $34.48 that expired on January 4, 2026, while other options remain outstanding with exercise prices between $27.14 and $55.68 and expirations in 2027 and 2028.

Halliburton Company reported that its Senior Vice President and Treasurer acquired additional common stock through an equity award. On January 2, 2026, the officer was granted 5,610 shares of common stock under the Halliburton Company Stock and Incentive Plan, which allows shares to be surrendered to cover withholding taxes. The grant used the New York Stock Exchange closing price of $29.60 per share on the grant date. Following this award, the officer directly owned 82,736 shares of Halliburton common stock. The filing also lists existing stock options to buy Halliburton common shares at exercise prices of $31.44, $43.38, and $53.54, with expiration dates ranging from December 2026 to December 2028.

Halliburton Company executive reports new stock award. A senior vice president of Halliburton received an award of 5,610 shares of common stock on January 2, 2026 under the Halliburton Company Stock and Incentive Plan. The plan allows shares to be surrendered back to Halliburton to cover tax withholding.

After this grant, the executive beneficially owns 51,738.081 shares of Halliburton common stock directly, which includes 937.667 shares acquired through the Employee Stock Purchase Plan for periods ending March 31, 2025 and June 30, 2025. The executive also holds vested options to buy 16,733 shares at $49.61 expiring January 2, 2028 and 14,197 shares at $55.68 expiring January 3, 2027.